Antibody Fragments Market with COVID-19 Impact Analysis, By Type (FAB, scFv, sdAb, Others), By Application (Cancer, Immunodeficiency, Others), By Specificity (Monoclonal Antibodies, Polyclonal Antibodies), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Antibody Fragments Market size was valued at USD 7,715.0 Billion in 2022, expanding at a CAGR of 6.8% from 2023 to 2030.
Antibody fragments are smaller portions of full-sized antibodies that retain the ability to bind to specific target molecules with high affinity. These fragments are derived from the variable regions of antibodies and typically lack the constant regions found in full antibodies. By removing the constant regions, antibody fragments offer advantages such as improved tissue penetration, rapid clearance from the body, and reduced immunogenicity. Common types of antibody fragments include Fab fragments, which consist of the variable regions and a portion of the constant region, and single-chain variable fragments (scFv), which are composed of a single polypeptide chain. Antibody fragments are widely used in various applications, including research, diagnostics, and therapeutic interventions.
Antibody Fragments Market- Market Dynamics
The development and utilization of antibody fragments are driven by several factors. One key driver is their potential to address limitations associated with full-sized antibodies. Antibody fragments offer improved tissue penetration, faster clearance from the body, and reduced immunogenicity, making them attractive for therapeutic applications. Additionally, the smaller size of antibody fragments enables easier manufacturing, lower production costs, and improved stability compared to full-sized antibodies. Their versatility and modularity allow for the design of novel formats and engineered variants with enhanced properties. Furthermore, advancements in antibody engineering and recombinant DNA technology have facilitated the production and optimization of antibody fragments, driving their adoption in research, diagnostics, and therapeutic industries.
One restraint of antibody fragments is their reduced serum half-life compared to full-sized antibodies, which may limit their therapeutic efficacy. Additionally, the smaller size of antibody fragments may result in lower binding affinity or specificity compared to full antibodies, requiring careful selection and optimization of fragments for desired applications.
Antibody Fragments Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is a leading region in the development, production, and utilization of antibody fragments. The presence of renowned research institutions, biotechnology companies, and pharmaceutical giants has contributed to the growth of the antibody fragment field. In North America, there is a strong focus on innovation and technological advancements in antibody engineering and recombinant DNA technology, driving the development of novel antibody fragment formats and optimization strategies. The region's well-established infrastructure for biopharmaceutical research and manufacturing, along with regulatory expertise, supports the translation of antibody fragments into clinical applications. Additionally, the robust investment in research and development, combined with a favorable intellectual property landscape, further fosters the growth of antibody fragment-based therapies and diagnostics in North America. As of December 2021, the United States of America exported around USD47,810,590.631 valued medical and pharmaceutical products. Adding to this, the US is the biggest market for pharmaceutical industries, according to US Pharmaceutical Industry Statistics.
Antibody Fragments Market- Competitive Landscape:
The competitive landscape of antibody fragments is highly dynamic and characterized by a mix of established pharmaceutical companies, biotechnology firms, and specialized antibody technology providers. Major pharmaceutical companies have made significant investments in antibody fragment research and development to expand their therapeutic portfolios. Biotechnology companies, including those focused on antibody therapeutics, often have proprietary platforms for antibody fragment discovery and optimization. Additionally, specialized antibody technology providers offer advanced antibody engineering and production services to support the development of antibody fragments. Competition is driven by factors such as the ability to generate high-affinity and specific antibody fragments, production scalability, intellectual property, and clinical success. Collaboration and licensing agreements between companies are common strategies to leverage complementary capabilities and drive innovation in the field. In February 2022, Emerging new therapeutic antibody derivatives for cancer treatment. Monoclonal antibodies constitute a promising class of targeted anticancer agents that enhance natural immune system functions to suppress cancer cell activity and eliminate cancer cells. The successful application of IgG monoclonal antibodies has inspired the development of various types of therapeutic antibodies, such as antibody fragments, bispecific antibodies, and antibody derivatives
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL ANTIBODY FRAGMENTS MARKET KEY PLAYERS
- Genentech
- AbbVie Inc.
- Albynx, a Sanofi Company
- Johnson and Johnson
- Pfizer Inc.
- Bristol-Myers Squibb
- Eli Lilly
- Novartis AG
- Aptevo Therapeutics
- Crescendo Biologics
- IONTAS
- MacroGenics
- CytomX Therapeutics
- Biologics Modular (BMG) Labtech
- AvantGen
GLOBAL ANTIBODY FRAGMENTS MARKET, BY SPECIFICITY
- Monoclonal Antibodies
- Polyclonal Antibodies
GLOBAL ANTIBODY FRAGMENTS MARKET, BY TYPE
- FAB
- scFv
- sdAb
- Others
GLOBAL ANTIBODY FRAGMENTS MARKET, BY APPLICATION
- Cancer
- Immunodeficiency
- Others
GLOBAL ANTIBODY FRAGMENTS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Antibody Fragments Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Antibody Fragments Market Snippet by Specificity
2.1.2. Antibody Fragments Market Snippet by Type
2.1.3. Antibody Fragments Market Snippet by Application
2.1.4. Antibody Fragments Market Snippet by Country
2.1.5. Antibody Fragments Market Snippet by Region
2.2. Competitive Insights
3. Antibody Fragments Key Market Trends
3.1. Antibody Fragments Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Antibody Fragments Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Antibody Fragments Market Opportunities
3.4. Antibody Fragments Market Future Trends
4. Antibody Fragments Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Antibody Fragments Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Antibody Fragments Market Landscape
6.1. Antibody Fragments Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Antibody Fragments Market – By Specificity
7.1. Overview
7.1.1. Segment Share Analysis, By Specificity, 2022 & 2030 (%)
7.1.2. Monoclonal Antibodies
7.1.3. Polyclonal Antibodies
8. Antibody Fragments Market – By Type
8.1. Overview
8.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
8.1.2. FAB
8.1.3. scFv
8.1.4. sdAb
8.1.5. Others
9. Antibody Fragments Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
9.1.2. Cancer
9.1.3. Immunodeficiency
9.1.4. Others
10. Antibody Fragments Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
10.2.1. Overview
10.2.2. Antibody Fragments Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.2.4. North America Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.2.5. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Antibody Fragments Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.11. Russia
10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.11.2. Russia Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.11.3. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.12. Netherlands
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.12.2. Netherlands Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.12.3. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.13. Sweden
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.13.2. Sweden Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.14. Poland
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.14.2. Poland Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.14.3. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.3.15. Rest of Europe
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.3.15.3. Rest of the Europe Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.3.15.4. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Antibody Fragments Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Antibody Fragments Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Antibody Fragments Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Specificity, 2018 - 2030 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
11. Key Vendor Analysis- Antibody Fragments Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Genentech
11.2.2. AbbVie Inc.
11.2.3. Albynx, a Sanofi Company
11.2.4. Johnson and Johnson
11.2.5. Pfizer Inc.
11.2.6. Bristol-Myers Squibb
11.2.7. Eli Lilly
11.2.8. Novartis AG
11.2.9. Aptevo Therapeutics
11.2.10. Crescendo Biologics
11.2.11. IONTAS
11.2.12. MacroGenics
11.2.13. CytomX Therapeutics
11.2.14. Biologics Modular (BMG) Labtech
11.2.15. AvantGen
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
